It has been shown that PAR-1 knockout mice have less fibrosis than wild types after treatment with carbon tetrachloride [46], and administration of a PAR-1 antagonist to mice subject to bile duct ligation leads to a reduction in hepatic fibrosis [47]. This evidence concerns the gene F2R and Hepatic fibrosis.